Should I buy Procter & Gamble (PG) stock or is it too late?
⭐ The most reliable of them, either direction: JP Morgan — 62% of its targets hit on this sector (373 calls tested). It aims for $162 (+13 %), call made on July 17, 2026, maturing on July 17, 2027 (42 d ago).
Firm-by-firm track record on Procter & Gamble
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| B of A Securities | 70 % | +13.1 % | 10 | $166 +16% |
| Citigroup | 68 % | +9.5 % | 19 | $170 +19% |
| Morgan Stanley | 77 % | +8.1 % | 22 | $180 +26% |
| Jefferies | 86 % | +7.5 % | 7 | $179 +25% |
| Deutsche Bank | 69 % | +6.2 % | 26 | $162 +13% |
| Barclays | 72 % | +5.0 % | 18 | $152 +6% |
| Wells Fargo | 62 % | +2.7 % | 16 | $164 +15% |
| Raymond James | 56 % | +2.1 % | 9 | $175 +22% |
✅ Reasons to believe
- Median price target $162, i.e. +13% from the current price ($143).
- The most reliable firm on PG, Jefferies (86% hit rate, 7 scored calls), targets $179 (call made on December 17, 2025, maturing on December 17, 2026) (+25%) in its most recent call.
- Pays a dividend (2.9% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 13 ratings, 8 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on PG
Median target $162 (+13%) · 13 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Procter & Gamble now?
We won't decide for you. The facts: 38% of analysts rate it a buy, median target $162 (+13%), and Jefferies (most reliable on PG, 86%) targets $179. Weigh that against valuation (P/E ~22). This is not personalized advice.
Is it too late to invest in Procter & Gamble?
Not according to analysts: the median target ($162) is still +13% above the current price ($143) (most reliable on PG: Jefferies, 86%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Procter & Gamble still worth investing in?
It depends on the gap between the price ($143) and its estimated value: analysts target $162 on median (+13%), with 38% buys (most reliable on PG: Jefferies, 86%). Cross-check with their real reliability on PG and the cautions above. Information, not advice.
What's the main risk in buying PG?
The consensus is not unanimous: of 13 ratings, 8 are neutral.
→ Go deeper: the full Procter & Gamble profile (consensus, analyst reliability, price target, performance).